Skip to main content
Clinical Trials/NCT02134691
NCT02134691
Completed
Not Applicable

Randomized Trial of Prolonged Exposure for the Treatment of Posttraumatic Stress Disorder (PTSD)

University of Puerto Rico1 site in 1 country98 target enrollmentAugust 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Posttraumatic Stress Disorder
Sponsor
University of Puerto Rico
Enrollment
98
Locations
1
Primary Endpoint
Change in Clinician Administered PTSD Scales (CAPS)
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This project will examine the impact of PE therapy for the treatment of PTSD with a sample of Latinos. The need to provide effective treatment to Spanish-speaking Latinos with PTSD is critical given the high prevalence of PTSD among Latinos. Furthermore, PTSD remains an under detected and under treated condition. Untreated PTSD has a substantial impact on health, functioning and quality of life. PE is one of the most empirically supported psychological interventions for PTSD. However, most studies that evidence the efficacy of PE have been conducted mainly with English-speaking Caucasian populations. This study has the potential to contribute to improvements in the well-being of Spanish-speaking Latinos with PTSD.

Registry
clinicaltrials.gov
Start Date
August 2013
End Date
February 28, 2019
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mildred Vera

Professor

University of Puerto Rico

Eligibility Criteria

Inclusion Criteria

  • 18 to \< 65 years
  • Meet diagnostic criteria for PTSD
  • Spanish speaker
  • Allow recording of assessments and therapy

Exclusion Criteria

  • Significant current suicidal or homicidal ideation
  • History of bipolar, schizophrenia or psychotic disorder
  • Alcohol or drug abuse during the past three months
  • Current high risk of being assaulted (i.e., living with domestic violence)
  • Current psychotherapy to treat PTSD
  • Unable to provide informed consent

Outcomes

Primary Outcomes

Change in Clinician Administered PTSD Scales (CAPS)

Time Frame: 6 months

Secondary Outcomes

  • Change in Sheehan Disability Scale(6 months)
  • Change in SF-12(6 months)

Study Sites (1)

Loading locations...

Similar Trials